Home Search
cancer - search results
If you're not happy with the results, please do another search
ARM-002TM anti-cancer vaccine shows promise in combatting pre-established melanoma
Defence Therapeutics Inc. has unveiled the exceptional efficacy of its second-generation ARMTM anti-cancer vaccine.
The anti-cancer vaccine, dubbed ARM-002TM, has demonstrated proficiency in combating pre-established...
NHS cancer checks more than doubled in the last decade
NHS cancer checks have topped three million in a year for the first time, more than doubling in the last decade.
Spread of triple-negative breast cancer fuelled by softer tumours
Researchers have found how the mechanical properties of triple-negative breast tumours can influence how their cancerous cells spread to other organs.
According to new findings...
Defence Therapeutics announces successful ARM-002TM cancer vaccine results
Defence Therapeutics has announced the successful testing of its second-generation anti-cancer vaccine, named ARM-002TM, utilising its flagship anti-cancer molecule, AccuTOX®.
The ARM-002TM cancer vaccine, when...
NHS pilot trials lung cancer blood test across thousands of patients
The NHS is conducting trials for a groundbreaking lung cancer blood test to detect the disease at its earliest stages.
Scientists identify protein interface that drives cancer growth
For the first time, researchers have shown that the protein interface that drives cancer growth could act as a target for more effective treatments.
Led...
New endometrial cancer immunotherapy approved by the NHS
The NHS is set to introduce an immunotherapy that could potentially provide significant additional time for women battling endometrial cancer.
Anti-diabetic drugs may lower brain cancer risk, says the University of Bristol
Researchers from the University of Bristol have uncovered a potential link between long-term use of certain anti-diabetic drugs and a reduced risk of primary...
NHS introduces routine bowel cancer screening for Lynch syndrome patients
The NHS has announced it is offering routine bowel cancer screening to thousands of individuals with Lynch syndrome.
Tohoku University develops monoclonal antibody for HER2-positive breast cancer
Tohoku University have engineered a groundbreaking monoclonal antibody aimed at HER2-positive breast cancer.
Improvements in cancer survival rates slowing, say Cancer Research UK
Ahead of World Cancer Day on Sunday, Cancer Research UK has revealed that improvements in cancer survival rates have slowed in recent years.
BRCA gene testing programme launched by NHS to identify cancer risk
Tens of thousands of people with Jewish ancestry are set to benefit from a pioneering BRCA gene testing programme unveiled by the NHS.
The BRCA...
Defence Therapeutics’ breakthrough in cancer treatment: AccuTOX® shows promise against lung tumours
Defence Therapeutics has announced the successful testing of a new formulation of its ACCUM-002TM Dimer CDCA-SV40 against lung tumours.
AI-driven screening identifies high breast cancer risk in mammograms
Cutting-edge technology harnessing Artificial Intelligence (AI) is revolutionising the early detection of breast cancer, pinpointing women at high risk through mammography screening examinations.
Led by...
NHS initiative introduces urinal mats carrying male cancer warning messages
Public toilets in England are set to feature urinal mats carrying crucial warnings about blood in urine to promote cancer symptoms in men.
New Cancer Research UK manifesto aims to avoid 20,000 UK cancer deaths per year
Cancer Research UK has launched a new manifesto urging the next UK Government to take action to prevent 20,000 avoidable UK cancer deaths annually...
AccuTOX® anticancer drug demonstrates exciting antigen cross-presentation
Defence Therapeutics Inc., a prominent Canadian biopharmaceutical company renowned for its work in immune-oncology vaccines and drug delivery technologies, has announced the discovery of...
Defence Therapeutics Inc. releases Accum® study revealing its anti-cancer properties
Defence Therapeutics Inc. have announced the publication of a peer-reviewed study on the anti-cancer properties of its unconjugated Accum®.
Researchers discover new target to combat cancer drug resistance
In a groundbreaking development, scientists at the University of Queensland have pinpointed a novel drug target with immense promise in combating cancer drug resistance...
How Defence’s Accum® technology is advancing cancer therapeutics
Industry-leading biotechnology pioneer Defence Therapeutics details how the company is advancing immune oncology through its revolutionary Accum® technology.
Whether using an antibody, cell-based vaccine or...
